SLSN NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Solesence, Inc. Common Stock · Consumer Defensive · Household & Personal Products

Open interactive chart View report data Download investor PDF
Latest close 0.94 USD
21.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -20.8% below the Trend Line and sits at 8.3% of its 52-week range. The latest completed week returned 21.3%, after a 13.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 44/100. Near-term considerations: volume confirmation is below normal; earnings are due in 0d.

Setup score 24 out of 100
Latest Close 0.94 USD 24 Jul 2026
1W Return 21.3% latest completed week
4W Return 13.9% short-term follow-through
12W Return -29.9% quarterly tape
Trend Breadth 26.9% 14 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 21.3% Latest completed week; four-week move 13.9%. Indicator stack 15/34 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 44.40% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 44/100 34 relevant articles in the latest sentiment read. Event risk 0d Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -20.8% below the Trend Line and sits at 8.3% of its 52-week range. The latest completed week returned 21.3%, after a 13.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1512-week average 0.16

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.15Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 13.9% over four weeks, -29.9% over 12 weeks, and -78.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W21.3%
4W13.9%
12W-29.9%
26W-36.5%
52W-78.3%
Active trend streak0 weeks
Active weeks in one year14
Trend breadth26.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.29Latest activity-pressure read.
Pressure change-136.7%Four-week change in activity pressure.
Leadership-57.20Latest relative-leadership reading.
RS change16.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength1/100Blend of value, momentum, and quality. Underlying universe rank 100; rank 1 is best.
Value7/100Relative valuation strength. Underlying universe rank 94; rank 1 is best.
Quality7/100Profitability and accounting quality. Underlying universe rank 94; rank 1 is best.
Momentum1/100Medium-term price momentum. Underlying universe rank 100; rank 1 is best.
Growth10/100Revenue and earnings growth. Underlying universe rank 91; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework8/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
70.3x
Price divided by trailing earnings.
Price / sales
1.1x
Market value relative to trailing revenue.
EV / EBITDA
29.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
26.5%
Gross profit retained from each unit of revenue.
Operating margin
3.4%
Operating profit retained from revenue.
Free-cash-flow margin
6.3%
Free cash flow generated from revenue.
Return on invested capital
4.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
5.8%
Latest one-year revenue growth.
EPS growth
-72.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
23.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
7.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment44/100

Weighted news tone is neutral across 34 relevant articles.

3 positive · 19 neutral · 12 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings0dNext report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-79.3%Distance below the 52-week high.
13-week volatility14.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+54.1%Week of 3 Apr.
Worst week-38.4%Week of 26 Jun.
Latest week+21.3%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains7
Flat weeks0
Modest losses4
Sharp losses9
Recent vol14.5%13-week weekly-return volatility.
Base vol15.3%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew9.6% / -11.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape19/100

Trend, activity pressure, participation, and risk combine to a 19/100 tape read.

 Indicator analysis29/100

Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 0/12.

Activity pressure 0.15; No reversal markers Next-Week ExpectancyNegative 44.40%

Next-week expectancy is negative with a 44.40% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors3/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 60; Small Cap Core rank 95 SVQF8/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 671.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment44/100

Weighted news tone is neutral across 34 relevant articles.

Solesence Ord Shs (SLSN) Earnings Forecast: Future EPS & Revenue Growth Estimates Insiders50/100

No recent insider transaction evidence is stored.

 Earnings0d

Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20260.94 USD21.3%1.19 USD1.85 USD-0.29-57.20376.6KOff
17 Jul 20260.78 USD14.7%1.22 USD1.86 USD-0.10-66.541.9MOff
10 Jul 20260.68 USD-1.0%1.26 USD1.86 USD0.14-72.99219.0KOff
3 Jul 20260.68 USD-17.3%1.30 USD1.86 USD0.60-73.00510.4KOff
26 Jun 20260.82 USD-38.4%1.35 USD1.87 USD0.80-68.152.1MOff
19 Jun 20261.34 USD0.8%1.40 USD1.87 USD0.86-52.29170.8KOff
12 Jun 20261.33 USD1.5%1.43 USD1.87 USD0.78-53.31208.8KOff
5 Jun 20261.31 USD6.5%1.44 USD1.87 USD0.77-54.26139.7KOff
29 May 20261.23 USD-1.2%1.50 USD1.87 USD0.80-60.02198.8KOff
22 May 20261.25 USD2.9%1.57 USD1.87 USD0.82-59.44166.3KOff
15 May 20261.21 USD-10.4%1.65 USD1.87 USD0.84-61.09275.4KOff
8 May 20261.35 USD0.7%1.73 USD1.87 USD0.73-57.73149.5KOff
1 May 20261.34 USD10.7%1.81 USD1.86 USD0.68-56.68197.2KOff
24 Apr 20261.21 USD-3.2%1.90 USD1.86 USD0.71-61.01232.3KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.